Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;16(4):219-24.
doi: 10.4103/0974-9233.58425.

Behçet's Uveitis

Affiliations

Behçet's Uveitis

Ilknur Tugal-Tutkun. Middle East Afr J Ophthalmol. 2009 Oct.

Abstract

Behçet's disease is a multisystem inflammatory disorder that is most common in countries along the ancient "Silk Road". The eye is the most commonly involved vital organ in Behçet's patients and the typical form of involvement is a relapsing remitting panuveitis and retinal vasculitis. Uveitis is the initial manifestation of the disease in 10-15% of the patients. Anterior uveitis is always nongranulomatous. Diffuse vitritis, retinal infiltrates, sheathing of predominantly retinal veins, and occlusive vasculitis are the typical signs of posterior segment inflammation. Spontaneous resolution of acute inflammatory signs is a diagnostic feature. Fundus fluorescein angiography is the gold standard in monitoring inflammatory activity. Laser flare photometry is a useful noninvasive tool since flare readings correlate with fluorescein angiographic leakage. The most common complications are cataract, maculopathy, and optic atrophy. Male patients have a more severe disease course and worse visual prognosis. Immunomodulatory therapy is indicated in all patients with posterior segment involvement. Corticosteroids combined with azathioprine and/or cyclosporine is used initially. Biologic agents, including interferon alfa and infliximab, are used in resistant cases. Visual prognosis has improved in recent years with an earlier and more aggressive use of immunomodulatory therapy and the use of biologic agents in resistant cases.

Keywords: Behçet's Disease; Immunomodulatory Treatment; Retinal Vasculitis; Uveitis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1a
Figure 1a
(a) A 27 year-old pregnant woman with Behçet's disease presented with a hypopyon panuveitis;
Figure 1b
Figure 1b
(b)with multifocal retinal infiltrates;
Figure 1c
Figure 1c
(c)Spontaneous resolution of the retinal infiltrates and accumulation of precipitates on the surface of the inferior peripheral retina were noted one week later
Figure 2a
Figure 2a
(a)Color fundus photograph of the left eye of a patient with Behçet's disease shows retinal hemorrhages at the posterior pole and at the superior temporal quadrant following an episode of superior temporal branch retinal vein occlusion
Figure 2b
Figure 2b
(b) fluorescein angiography shows staining of the optic disc as well as inflamed retinal vessels and hypofluorescence due to retinal hemorrhages and nonperfusion of the retinal vasculature at the involved quadrant
Figure 3
Figure 3
Color photograph shows end-stage fundus picture in the left eye of a patient with Behçet's disease. Please note optic atrophy, gliotic vascular sheathing, ghost vessels, and diffuse retinal atrophy with pigmentation resembling retinitis pigmentosa

Similar articles

  • [Ocular manifestations in Behçet's disease].
    Desbois AC, Terrada C, Cacoub P, Bodaghi B, Saadoun D. Desbois AC, et al. Rev Med Interne. 2018 Sep;39(9):738-745. doi: 10.1016/j.revmed.2018.02.022. Epub 2018 Apr 4. Rev Med Interne. 2018. PMID: 29625716 Review. French.
  • Clinical features of chinese patients with Behçet's disease.
    Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A. Yang P, et al. Ophthalmology. 2008 Feb;115(2):312-318.e4. doi: 10.1016/j.ophtha.2007.04.056. Epub 2007 Aug 10. Ophthalmology. 2008. PMID: 17692378
  • [Ocular manifestations in Behçet's disease].
    Zeghidi H, Saadoun D, Bodaghi B. Zeghidi H, et al. Rev Med Interne. 2014 Feb;35(2):97-102. doi: 10.1016/j.revmed.2013.10.011. Epub 2013 Nov 27. Rev Med Interne. 2014. PMID: 24290834 Review. French.
  • [Eye and Behçet's disease].
    Ksiaa I, Abroug N, Kechida M, Zina S, Jelliti B, Khochtali S, Attia S, Khairallah M. Ksiaa I, et al. J Fr Ophtalmol. 2019 Jun;42(6):626-641. doi: 10.1016/j.jfo.2018.09.027. Epub 2019 Jun 1. J Fr Ophtalmol. 2019. PMID: 31164292 Review. French.
  • Behçet's Uveitis: Current Diagnostic and Therapeutic Approach.
    Çakar Özdal P. Çakar Özdal P. Turk J Ophthalmol. 2020 Jun 27;50(3):169-182. doi: 10.4274/tjo.galenos.2019.60308. Turk J Ophthalmol. 2020. PMID: 32631005 Free PMC article. Review.

Cited by

References

    1. Behçet H. über rezidivierende aphthöse durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatol Wochenschr. 1937;105:1152–7.
    1. Evereklioglu C. Current concepts in the etiology and treatment of Behçet disease. Surv Ophthalmol. 2005;50:297–350. - PubMed
    1. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behçet's disease, the Silk Road and HLA-B51: Historical and geographical perspectives. Tissue Antigens. 1999;54:213–20. - PubMed
    1. Keino H, Okada AA. Behçet's disease: Global epidemiology of an old Silk Road disease. Br J Ophthalmol. 2007;91:1573–4. - PMC - PubMed
    1. Azizlerli G, Köse AA, Sarica R, Gül A, Tutkun IT, Kulaç M, et al. Prevalence of Behçet's disease in Istanbul, Turkey. Int J Dermatol. 2003;42:803–6. - PubMed